{
    "2020-04-20": [
        [
            {
                "time": "2020-04-15",
                "original_text": "Pharma giant acquires Phoenix-based startup developing eye treatments",
                "features": {
                    "keywords": [
                        "acquires",
                        "startup",
                        "eye treatments"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-16",
                "original_text": "U.S. stocks finish near session lows as oil market crash overshadows plans to ease global lockdowns",
                "features": {
                    "keywords": [
                        "stocks",
                        "session lows",
                        "oil market crash",
                        "lockdowns"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-17",
                "original_text": "Coronavirus update: 2.44 million cases worldwide, 167,369 deaths; and U.S. restaurants seek billions in federal aid",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "cases",
                        "deaths",
                        "federal aid"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "hospitality"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-18",
                "original_text": "Novartis To Initiate Hydroxychloroquine Study for Coronavirus",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Hydroxychloroquine",
                        "Coronavirus"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-19",
                "original_text": "Coronavirus update: 2.42 million cases worldwide, 166,256 deaths; and U.S. restaurants seek billions in federal aid",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "cases",
                        "deaths",
                        "federal aid"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "hospitality"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-20",
                "original_text": "Novartis Gets FDA Nod to Start Malaria Drug Trial For Coronavirus Cure",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA",
                        "Malaria Drug",
                        "Coronavirus"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-21",
                "original_text": "Novartis to run COVID-19 trial of antimalaria drug touted by Trump",
                "features": {
                    "keywords": [
                        "Novartis",
                        "COVID-19",
                        "antimalaria drug",
                        "Trump"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-22",
                "original_text": "Novartis to Test Anti-Malaria Drug as Potential Coronavirus Treatment",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Anti-Malaria Drug",
                        "Coronavirus"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-23",
                "original_text": "Dow, S&P 500 futures down about 2% as investors weigh global lockdown easings, tanking oil",
                "features": {
                    "keywords": [
                        "Dow",
                        "S&P 500",
                        "futures",
                        "lockdown easings",
                        "oil"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-24",
                "original_text": "Why The Coronavirus Won't Shake Biotechs From Investing In China",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Biotechs",
                        "China"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-25",
                "original_text": "European stocks extend rally as recovery hopes continue",
                "features": {
                    "keywords": [
                        "European stocks",
                        "rally",
                        "recovery hopes"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-26",
                "original_text": "Novartis Buys U.S. Start-Up Amblyotech For Lazy Eye Treatment",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Amblyotech",
                        "Lazy Eye Treatment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-27",
                "original_text": "Novartis to test efficacy of old malaria drug against COVID-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "malaria drug",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-28",
                "original_text": "Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19",
                "features": {
                    "keywords": [
                        "Novartis",
                        "drug regulator",
                        "malaria drug",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-29",
                "original_text": "Novartis to conduct hydroxychloroquine trial for hospitalized COVID-19 patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "hydroxychloroquine",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}